Teleflex’s TFX escalating operating expenses are putting immense pressure on the bottom line. Tough competition and pricing pressure also weigh on the stock. The stock currently carries a Zacks Rank ...

PROVIDENCE, R.I. (WJAR) — There is a new treatment option for men who are adversely affected by an enlarged prostate. "Fifty percent of men at the age of 50 will have some problems with BPH or, the ...

Dr. Irina Jaeger, director of urology at University Hospitals Richmond Medical Center, is making UroLift treatment for benign prostatic hypertrophy, or BPH, available in the area for the first time.

Teleflex Incorporated presented new clinical data at the 2025 American Urological Association Annual Meeting, highlighting the UroLift™ System as a leading minimally invasive treatment for benign ...